Maternal Gut Microbiome as a Predictor of Insulin Therapy Requirement in Gestational Diabetes
Our findings demonstrate that integrating gut microbiome characteristics with clinical data improves the prediction of insulin treatment needs in GDM, particularly for BI initiation.
Authors
- Polina Popova (ORCID: https://orcid.org/0000-0002-3697-7791)
- S. I. Sitkin
- Alexandra Tkachuk
- Carmel Even (ORCID: https://orcid.org/0000-0003-1904-3951)
- Soha Zgairy
- Elena Vasukova (ORCID: https://orcid.org/0000-0002-8795-1495)
- Artem Isakov (ORCID: https://orcid.org/0000-0002-2938-0575)
- A. D. Liaudanski (ORCID: https://orcid.org/0000-0002-3325-0917)
- Alexander A. Loboda
- Angelina I. Eriskovskaya (ORCID: https://orcid.org/0000-0003-4874-4618)
- I. V. Galyautdinov
- Elena Vasilieva
- Irina S. Nemikina
- Anna A. Kostareva
- Omry Koren
- Evgeny V. Shlyakhto
- Tatiana M. Pervunina
- Aleksandra S Vatian
- Alina Babenko
- Elad Rubin
- Viswanathan Mohan
- Maria Akhmatova
- Sondra Turjeman
- Elena N. Grineva
- Anna D. Anopova
Institutions
- Bar-Ilan University (IL)
- Federal Almazov North-West Medical Research Centre (RU)
- Madras Diabetes Research Foundation (IN)
- Institute of Genetics and Cytology of the National Academy of Sciences of Belarus (BY)
- Saint Petersburg Stieglitz State Academy of Art and Design (RU)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1177/19322968261426025
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministero dello Sviluppo Economico